A transcriptionally and functionally distinct PD-1+ CD8+ T cell pool with predictive potential in non-small-cell lung cancer treated with PD-1 blockade

Daniela S. Thommen(University Hospital of Basel), Viktor H. Koelzer(University of Oxford), Petra Herzig(University Hospital of Basel), Andreas Roller(Roche (Switzerland)), Marcel P. Trefny(University Hospital of Basel), Sarah Dimeloe(University Hospital of Basel), Anna Kiialainen(Roche (Switzerland)), Jonathan Hanhart, Catherine Schill, Christoph Hess(University Hospital of Basel), Spasenija Savic Prince(University Hospital of Basel), Mark Wiese(University Hospital of Basel), Didier Lardinois(University Hospital of Basel), Ping‐Chih Ho(Ludwig Cancer Research), Christian Klein(Roche (Switzerland)), Vaios Karanikas(Roche (Switzerland)), Kirsten D. Mertz, Ton N. Schumacher(The Netherlands Cancer Institute), Alfred Zippelius(University Hospital of Basel)
Nature Medicine
June 8, 2018
10.1038/s41591-018-0057-z
Cited by 1,177Open Access
Full Text

Abstract

Related Papers

Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
Robert D. Schreiber, Lloyd J. Old, Mark J. Smyth|Science|2011|6.4k
Cancer immunotherapy comes of age
Ira Mellman, George Coukos, Glenn Dranoff|Nature|2011|3.9k
PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression
Cheryl L. Day, Daniel E. Kaufmann, Photini Kiepiela et al.|Nature|2006|2.6k
Molecular Signature of CD8+ T Cell Exhaustion during Chronic Viral Infection
E. John Wherry, Sang‐Jun Ha, Susan M. Kaech et al.|Immunity|2007|2.1k
Tumor antigen–specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired
Mojgan Ahmadzadeh, Laura A. Johnson, Bianca Heemskerk et al.|Blood|2009|1.8k